HUP0402326A2 - Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében - Google Patents

Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében

Info

Publication number
HUP0402326A2
HUP0402326A2 HU0402326A HUP0402326A HUP0402326A2 HU P0402326 A2 HUP0402326 A2 HU P0402326A2 HU 0402326 A HU0402326 A HU 0402326A HU P0402326 A HUP0402326 A HU P0402326A HU P0402326 A2 HUP0402326 A2 HU P0402326A2
Authority
HU
Hungary
Prior art keywords
addiction
prevention
pharmaceutical composition
pain management
pain
Prior art date
Application number
HU0402326A
Other languages
English (en)
Inventor
Stephen L. Dewey
Jonathan D. Brodie
Charles R. Ashby
Original Assignee
Brookhaven Science Associates
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Associates filed Critical Brookhaven Science Associates
Publication of HUP0402326A2 publication Critical patent/HUP0402326A2/hu
Publication of HUP0402326A3 publication Critical patent/HUP0402326A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány addikció (gyógyszer-függőség) megelőzésére vonatkozikfájdalom kezelésében. A találmány tárgya egy kompozíció fájdalomkezelésére emlősökben, amely tartalmaz: a) egy gyógyászatilagelfogadható analgetikumot, amely gyógyszerfüggővé tevő tulajdonságú,és b) egy GABAerg szert, amely hatékony az analgetikumgyógyszerfüggővé tevésének csökkentésében vagy eliminálásában. Atalálmány szerinti kompozíció beadásával megelőzhető azanalgetikumokhoz, különösen a narkotikus analgetikumokhoz történőhozzászokás. Ó
HU0402326A 2001-05-14 2002-04-08 Pharmaceutical composition for prevention of addiction in pain management HUP0402326A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/853,548 US20020187996A1 (en) 2001-05-14 2001-05-14 Prevention of addiction in pain management
PCT/US2002/011072 WO2002091990A2 (en) 2001-05-14 2002-04-08 Prevention of addiction in pain management

Publications (2)

Publication Number Publication Date
HUP0402326A2 true HUP0402326A2 (hu) 2005-02-28
HUP0402326A3 HUP0402326A3 (en) 2008-04-28

Family

ID=25316324

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402326A HUP0402326A3 (en) 2001-05-14 2002-04-08 Pharmaceutical composition for prevention of addiction in pain management

Country Status (21)

Country Link
US (3) US20020187996A1 (hu)
EP (1) EP1392301B1 (hu)
JP (1) JP2004534029A (hu)
KR (1) KR20040020054A (hu)
CN (1) CN100528156C (hu)
AT (1) ATE473001T1 (hu)
AU (1) AU2002342533B2 (hu)
BR (1) BR0209613A (hu)
CA (1) CA2446639C (hu)
CZ (1) CZ20033380A3 (hu)
DE (1) DE60236927D1 (hu)
ES (1) ES2348637T3 (hu)
HR (1) HRP20030892A2 (hu)
HU (1) HUP0402326A3 (hu)
IL (1) IL158762A0 (hu)
MX (1) MXPA03010407A (hu)
NO (1) NO331509B1 (hu)
NZ (1) NZ529614A (hu)
PL (1) PL368505A1 (hu)
WO (1) WO2002091990A2 (hu)
YU (1) YU89003A (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL207845B1 (pl) * 2000-07-31 2011-02-28 Nycomed Danmark As Spray donosowy do dostarczania kompozycji farmaceutycznej zawierającej fentanyl i zastosowanie soli fentanylu do wytwarzania środka leczniczego
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20050043345A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN105497896A (zh) * 2015-03-31 2016-04-20 苏州大学 一种肿瘤耐药的靶点及其应用
CA3199166A1 (en) 2020-12-04 2022-06-09 Cecilia Jannette Munoz Martinez Stable, coated, and solid pharmaceutical drug composition containing an opioid analgesic and an antiepileptic to relieve pain
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6057368A (en) * 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior

Also Published As

Publication number Publication date
CZ20033380A3 (cs) 2005-03-16
IL158762A0 (en) 2004-05-12
BR0209613A (pt) 2004-12-07
US20030134868A1 (en) 2003-07-17
US20020187996A1 (en) 2002-12-12
JP2004534029A (ja) 2004-11-11
PL368505A1 (en) 2005-04-04
AU2002342533B2 (en) 2007-07-05
NZ529614A (en) 2006-08-31
ATE473001T1 (de) 2010-07-15
US20030004176A1 (en) 2003-01-02
NO20035038D0 (no) 2003-11-13
EP1392301A2 (en) 2004-03-03
EP1392301A4 (en) 2004-07-14
CA2446639C (en) 2010-11-02
CA2446639A1 (en) 2002-11-21
DE60236927D1 (de) 2010-08-19
HRP20030892A2 (en) 2005-08-31
CN100528156C (zh) 2009-08-19
YU89003A (sh) 2006-08-17
ES2348637T3 (es) 2010-12-10
HUP0402326A3 (en) 2008-04-28
EP1392301B1 (en) 2010-07-07
WO2002091990A3 (en) 2003-03-27
US6939876B2 (en) 2005-09-06
MXPA03010407A (es) 2004-05-05
NO331509B1 (no) 2012-01-16
CN1531431A (zh) 2004-09-22
WO2002091990A2 (en) 2002-11-21
KR20040020054A (ko) 2004-03-06

Similar Documents

Publication Publication Date Title
HUP0204163A2 (hu) Opioid agonistát és antagonistát tartalmazó szabályozott leadású készítmény és eljárás az előállítására
BR0212019A (pt) Formas de dosagem, métodos para o tratamento da dor, métodos de preparação de uma forma de dosagem e métodos para impedir o abuso de uma forma de dosagem
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
HUP0401191A2 (hu) Opioid agonistát, valamint leadható és álcázott antagonistát tartalmazó készítmények
HUP0101543A2 (hu) Női szexuális zavarok kezelésére szolgáló gyógyszerkészítmények
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
MXPA03007885A (es) Norbuprenorfina n-but-3-enilo y metodos de uso.
DE50114474D1 (de) Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen
HUP0000137A2 (hu) Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény
HUP0402326A2 (hu) Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében
BR0201974A (pt) Composição farmacêutica para tratamento de alterações do sono
IL166596A0 (en) Salt of morphine-6-glucoronide
HUP0203466A2 (hu) Egy NK1 receptor antagonista és egy GABA szerkezeti analóg szinergikus kombinációja és ezt tartalmazó gyógyszerkészítmény és alkalmazása
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
CA2433785A1 (en) Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
HUP0402358A2 (hu) Szelektív dopamin D4 receptor agonisták alkalmazása szexuális diszfunkciók kezelésére alkalmas gyógyszerkészítmény előállítására
EP0799618A3 (en) Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer
HUP0402062A2 (hu) Alkanoil-L-karnitin alkalmazása merevedési zavar kezelésére és ezt tartalmazó gyógyszerkészítmények
BR0313305A (pt) Agente analgésico para indivìduos recém-nascidos ou fetais
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion
HUP0401853A2 (hu) Gyógyászati készítmény, ami egy adenozin A1/A2 agonistát és nátrium-hidrogén csere inhibitort tartalmaz
AU2003273114A1 (en) Medicament component of berberine for the use of prevention and treatment of psycological dependence on and analgesic tolerance to morphine
BR0003648A (pt) Composições e métodos para tratar condições alérgicas e inflamatórias com tosse

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished